Novo Nordisk licenses Nanexa drug tech in deal worth up to €1.17 bln

Avacta presents trial design for pancreatic cancer drug AVA6103

Investing.com · News 18m ago

Is a 15.53% post-earnings run the start or end for this restaurant pick?

Investing.com · News 20m ago

Is a 15.53% post-earnings run the start or end for this restaurant pick?

Investing.com · Investing_news 20m ago

Abingdon Health opens US manufacturing facility in Wisconsin

Investing.com · News 22m ago

Crypto platform Bitget suspects North Korea is responsible for $352 million hack

CNBC · Markets 22m ago

German consumer confidence slumps as energy costs bite

Investing.com · News 23m ago

HelloFresh cuts 2026 outlook as marketing cuts hit customer growth

Investing.com · Investing_news 24m ago

HelloFresh cuts 2026 outlook as marketing cuts hit customer growth

Investing.com · News 24m ago

LendInvest completes £300m buy-to-let mortgage securitisation

Investing.com · News 25m ago

Fermi selects CBRE to operate Texas data center facility

Investing.com · News 29m ago